SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Amgen says Tezspire safety profile matches approved indications

Amgen said Tezspire’s safety profile is consistent with its approved indications.

AMGN

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.